Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients: a referral center study.
Safarnezhad Tameshkel F, Karbalaie Niya MH, Zamani F, Motamed N, Ajdarkosh H, Vafaeimanesh J, Khoonsari M, Sohrabi MR, Aten S, Azarkeivan A, Eslami MS, Perumal D, Maadi M, Ghanbari B, Keyvani H. Safarnezhad Tameshkel F, et al. Among authors: eslami ms. Arch Virol. 2020 Oct;165(10):2193-2203. doi: 10.1007/s00705-020-04728-x. Epub 2020 Jul 8. Arch Virol. 2020. PMID: 32638116
The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background.
Neishabury M, Zamani F, Keyhani E, Azarkeivan A, Abedini SS, Eslami MS, Kakroodi ST, Vesiehsari MJ, Najmabadi H. Neishabury M, et al. Among authors: eslami ms. Blood Cells Mol Dis. 2013 Aug;51(2):80-4. doi: 10.1016/j.bcmd.2013.02.007. Epub 2013 Mar 28. Blood Cells Mol Dis. 2013. PMID: 23541515
CSMS committees work!
Eslami MS. Eslami MS. Conn Med. 1991 Apr;55(4):245. Conn Med. 1991. PMID: 2070610 No abstract available.
Medicaid in crisis.
Eslami MS. Eslami MS. Conn Med. 1991 Jan;55(1):55. Conn Med. 1991. PMID: 2049944 No abstract available.